experspadmin

Glucose-Lowering Agents and Cardiovascular Risk Reduction in Type 2 Diabetes
Endocrinology

Glucose-Lowering Agents and Cardiovascular Risk Reduction in Type 2 Diabetes

clinical topic updates
By Rita Rastogi Kalyani, MD, MHS, FACP
Chronic Lymphocytic Leukemia: Mechanisms of Resistance to Treatment
Oncology

Chronic Lymphocytic Leukemia: Mechanisms of Resistance to Treatment

clinical topic updates
By Matthew S. Davids, MD, MMSc
Exploring the Next-Generation Small-Molecule Inhibitors for Chronic Lymphocytic Leukemia
Oncology

Exploring the Next-Generation Small-Molecule Inhibitors for Chronic Lymphocytic Leukemia

clinical topic updates
By William G. Wierda, MD, PhD
The Role of Allogeneic Hematopoietic Stem Cell Transplantation in High-Risk Chronic Lymphocytic Leukemia
Oncology

The Role of Allogeneic Hematopoietic Stem Cell Transplantation in High-Risk Chronic Lymphocytic Leukemia

patient care perspectives
By William G. Wierda, MD, PhD
Reducing Toxicity From Chronic Lymphocytic Leukemia Treatment
Oncology

Reducing Toxicity From Chronic Lymphocytic Leukemia Treatment

patient care perspectives
Load More